Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Accumulated Expenses (2020 - 2025)

Sight Sciences has reported Accumulated Expenses over the past 6 years, most recently at $6.1 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $6.1 million for Q4 2025, down 37.25% from a year ago — trailing twelve months through Dec 2025 was $6.1 million (down 37.25% YoY), and the annual figure for FY2025 was $6.1 million, down 37.25%.
  • Accumulated Expenses for Q4 2025 was $6.1 million at Sight Sciences, down from $6.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for SGHT hit a ceiling of $9.7 million in Q4 2024 and a floor of $266000.0 in Q2 2022.
  • Median Accumulated Expenses over the past 5 years was $5.1 million (2025), compared with a mean of $4.8 million.
  • Biggest five-year swings in Accumulated Expenses: plummeted 93.49% in 2022 and later surged 1346.11% in 2024.
  • Sight Sciences' Accumulated Expenses stood at $6.0 million in 2021, then increased by 22.8% to $7.4 million in 2022, then plummeted by 38.41% to $4.5 million in 2023, then surged by 113.78% to $9.7 million in 2024, then crashed by 37.25% to $6.1 million in 2025.
  • The last three reported values for Accumulated Expenses were $6.1 million (Q4 2025), $6.2 million (Q3 2025), and $5.2 million (Q2 2025) per Business Quant data.